Indian Drugmakers Eye Insulin Market Share as Novo Nordisk Exits

Novo Nordisk, a big company that makes insulin pens, is stopping production of their disposable pens in India.

This creates a big opportunity for other Indian drug companies.

Companies like Eris Lifesciences and Wockhardt are preparing to take over this market by making their own insulin pens.

The market is worth a lot of money.

Novo is doing this to focus on different medicines.

While the pens are going away, some insulin in vials will still be available.

The price of insulin is unlikely to change a lot, but profits may be impacted.

Novo Nordisk wants to help people find alternative ways to get their insulin.